Drug delivery

  1. D-type mesoporous silica improved celecoxib delivery
    Chiral mesoporous silica carriers enhance celecoxib bioavailability and anti-inflammatory activity through hydrogen bonding and crystal-to-amorphous phase conversion.
  2. Validated HPLC method for clofazimine and pyrazinamide analysis
    RP-DAD-HPLC method development and ICH Q2 validation for simultaneous quantitative analysis of clofazimine and pyrazinamide in fixed-dose combination topical delivery systems.